Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in multiple sclerosis

S B Patten1, L M Metz

  • 1Alberta Heritage Foundation for Medical Research, Department of Community Health Sciences, Canada.

Psychotherapy and Psychosomatics
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal study examining the relationship between physical activity and psychiatric hospitalizations in canadian adolescents and young adults utilizing record linkage.

Scientific reports·2024
Same author

The factor structure of the Patient Health Questionnaire-9 in stroke: A comparison with a non-stroke population.

Journal of psychosomatic research·2024
Same author

Prevalence of Common Child Mental Health Disorders Using Administrative Health Data and Parent Report in a Prospective Community-Based Cohort from Alberta, Canada: Prévalence des troubles communs de santé mentale de l'enfant à l'aide des données de santé administratives et des rapports des parents dans une cohorte prospective communautaire d'Alberta, Canada.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2024
Same author

Understanding the impact of COVID-19 isolation measures on individuals with mood disorders in mental health clinics.

Journal of affective disorders reports·2022
Same author

Depression as a risk factor for the development of psoriasis: a retrospective cohort study in the UK.

The British journal of dermatology·2020
Same author

Safety of psychotropic medicines: looking beyond randomised evidence.

Epidemiology and psychiatric sciences·2018
Same journal

Schizophrenia Genetic Liability Drives Chronic Disease Risk in Unaffected Individuals Through Immune and Metabolic Pathways.

Psychotherapy and psychosomatics·2026
Same journal

Psychotherapy, Antidepressants, and Combined Treatment for Depression: A Network Meta-analysis on Social Functioning Outcomes.

Psychotherapy and psychosomatics·2026
Same journal

Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects.

Psychotherapy and psychosomatics·2026
Same journal

Clarifying Scope and Interpretation of Psychotherapeutic Consultation at Work: A Response to Recent Commentary.

Psychotherapy and psychosomatics·2026
Same journal

Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis.

Psychotherapy and psychosomatics·2026
Same journal

Does fatigue in patients with Post-COVID-19 Syndrome improve with rehabilitation?

Psychotherapy and psychosomatics·2026
See all related articles

Depression is common in multiple sclerosis (MS), with psychosocial factors playing a role. Antidepressant treatment may be effective, but more research is needed on various risk factors and therapies.

Area of Science:

  • Neurology
  • Psychiatry
  • Epidemiology

Background:

  • The association between multiple sclerosis (MS) and depression is well-established but not fully understood.
  • Significant knowledge gaps exist regarding the burden, causes, and treatment of depression in MS patients.

Purpose of the Study:

  • To critically review the existing literature on the burden, etiology, and treatment of depression in multiple sclerosis.
  • To identify areas for future research in understanding and managing depression in MS.

Main Methods:

  • A comprehensive literature review was conducted using Medline (1966-1996).
  • Citations from identified papers were used to supplement the search.

Main Results:

  • MS patients exhibit higher depressive symptom scores and prevalence rates compared to control groups.

Related Experiment Videos

  • No specific neurological pattern consistently links to depression in MS; psychosocial factors are implicated.
  • Evidence suggests antidepressant pharmacotherapy is effective for depression in MS.

    • Conclusions:

    • Future research should explore a broader range of biological, psychological, and social risk factors beyond neuropathology.
    • Further empirical studies are needed to refine and validate treatment approaches for depression in MS.